ReviewSeminars in oncology2016

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Robert H Shoemaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.